3,4-dihydro Naratriptan

Naratriptan is a selective serotonin 5-HT1B agonist (pKi = 8.9 for human 5-HT1B) used in the treatment of severe cephalic pain, including migraine headaches. 3,4-dihydro Naratriptan is an impurity formed during the preparation of naratriptan.Formal Name: N-methyl-3-(1,2,3,6-tetrahydro-1-methyl-4-pyridinyl)-1H-indole-5-ethanesulfonamide. CAS Number: 121679-20-7. Synonyms: Naratriptan Impurity B. Molecular Formula: C17H23N3O2S. Formula Weight: 333.4. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 10 mg/ml, DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml, DMSO: 10 mg/ml, Ethanol: 0.1 mg/ml. lambdamax: 228, 260, 285 nm. SMILES: O=S(CCC1=CC=C2C(C(C3=CCN(C)CC3)=CN2)=C1)(NC)=O. InChi Code: InChI=1S/C17H23N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-5,11-12,18-19H,6-10H2,1-2H3. InChi Key: UJPMSESNMYEKDD-UHFFFAOYSA-N.